Primary Peritoneal Cancer

Primary peritoneal cancer (PPC) is a rare malignancy closely related to epithelial ovarian cancer, originating from the peritoneum lining the abdominal cavity. Cancer research is pivotal in improving PPC outcomes, focusing on early detection, targeted therapies, and understanding genetic predispositions. Advances in genomic profiling have identified key mutations, facilitating personalized treatment approaches. Research into biomarkers is underway to develop non-invasive diagnostic tools, enhancing early detection rates. Additionally, innovative treatments like PARP inhibitors and immunotherapy are being explored to improve survival rates. Collaborative clinical trials continue to play a critical role, aiming to refine existing therapies and discover new ones, offering hope for PPC patients through cutting-edge scientific advancements.